Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 41 Show results per page	View Search Criteria \| Help With Results

Last Modified: 5/21/2007


1.		Phase I/II Study of Aminocamptothecin in Recurrent or Progressive Malignant Glioma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				over 18				NCI				NABTT-9506 MGH-NABTT-9506, NCI-T94-0169O, NABTT-9506

Last Modified: 5/21/2007


2.		Phase II/I/II Study of Pre-Irradiation Aminocamptothecin for Newly Diagnosed Adult Glioblastoma Multiforme

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				18 and over				NCI				NABTT-9505 JHOC-NABTT-9505, NCI-T94-0168O

Last Modified: 12/1/1997


3.		Phase II Study of 9-AC Administered by 72-Hour Continuous Infusion with or without G-CSF in Adults with Relapsed/Refractory Hodgkin's Disease or non-Hodgkin's Lymphoma (Summary Last Modified 12/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				NCI-94-C-0065C NCI-MB-322, NCI-T93-0122N, T93-0122

Last Modified: 6/1/1997


4.		Phase II Study of Aminocamptothecin in Stage IIIB/IV Nonsmall Cell Lung Cancer (Summary Last Modified 06/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				UCCRC-7485 NCI-T94-0144H, T94-0144

Last Modified: 6/1/1995


5.		Phase II Study of 9-AC in Fluorouracil-Refractory Colorectal Cancer (Summary Last Modified 06/95)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				MSKCC-94106 NCI-T94-0126D, T94-0126

Last Modified: 10/1/1997


6.		Phase II Study of Aminocamptothecin in Malignant Gliomas (Summary Last Modified 10/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				over 18				NCI				UCCRC-7484 NCI-T94-0147H, T94-0147

Last Modified: 9/1/1999


7.		Phase II Clinical and Pharmacologic Study of Aminocamptothecin in Advanced Ovarian Cancer (Summary Last Modified 09/1999)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				MSKCC-94126 NCI-T94-0127D, T94-0127

Last Modified: 4/1/1998


8.		Phase II Study of Aminocamptothecin in Advanced Nonsmall Cell Lung Cancer (Summary Last Modified 04/98)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				over 18				NCI				JHOC-T94-0133 NCI-T94-0133D, T94-0133

Last Modified: 8/1/2000


9.		Phase II Study of Continuous-Infusion Aminocamptothecin for Advanced Epithelial Ovarian Cancer Recurrent After Paclitaxel and Either Cisplatin or Carboplatin (Summary Last Modified 08/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				NCI-95-C-0056B NCI-CPB-357, NCI-T94-0164N, T94-0164

Last Modified: 3/1/2001


10.		Phase II Study of Aminocamptothecin by 72-Hour Infusion for Advanced Cutaneous T-Cell Lymphoma (Summary Last Modified 03/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				YALE-HIC-7862 NCI-T94-0189D, NCT00002635, T94-0189

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute